Anterix (ATEX) Research & Development (2013 - 2025)

Anterix has reported Research & Development for 13 years, with the latest figure at $1.1 million in Q4 2025.

• For the quarter ending Q4 2025, Research & Development fell 1.43% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (down 34.32% YoY), and the FY2025 full-year result was $5.7 million, up 0.67% from the prior year.
• Research & Development for Q4 2025 stood at $1.1 million, down from $1.2 million in the prior quarter.
• The five-year high for Research & Development was $2.2 million in Q1 2024, with the low at $767000.0 in Q1 2022.
• Historically, Research & Development has averaged $1.2 million across 5 years, with a median of $1.1 million in 2024.
• Annual changes were most pronounced in 2023 — Research & Development surged 86.05% — and 2025, when it plunged 51.45%.
• Anterix's Research & Development stood at $893000.0 in 2021, then climbed by 4.82% to $936000.0 in 2022, then surged by 32.26% to $1.2 million in 2023, then declined by 9.53% to $1.1 million in 2024, then retreated by 1.43% to $1.1 million in 2025.
• The last three Research & Development figures came in at $1.1 million (Q4 2025), $1.2 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.